Skip to main content
Journal ArticleOPEN ACCESS

Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity

Clinical Case Reports (2021) 9(4) 2132-2137
DOI: 10.1002/ccr3.3964
2Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID-19 patients with obesity and chronic diseases such as diabetes and hypertension.

Author supplied keywords

Cite

CITATION STYLE

APA

Das, S. K., Ranabhat, K., Bhattarai, S., Karki, K. B., Gyanwali, P., Paneru, H. R., … Acharya, S. P. (2021). Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity. Clinical Case Reports, 9(4), 2132–2137. https://doi.org/10.1002/ccr3.3964

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free